# OnCo record gyala-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/gyala-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "gyala-therapeutics" ;
  schema:name "Gyala Therapeutics"@en ;
  schema:description "Gyala Therapeutics develops CAR-T cell therapy, in which a patient's own immune cells are modified to attack leukaemia. Its first product targets a protein called CD84 and is in an early trial in acute myeloid leukaemia and T-cell acute lymphoblastic leukaemia that has come back or not responded."@en ;
  schema:url <https://onco.cc/companies/gyala-therapeutics/>, <https://gyalatx.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://gyalatx.com/>, <https://gyalatx.com/gyala-therapeutics-initiates-phase-i-iia-clinical-trial-of-a-car-t-cell-therapy-for-acute-leukemias-with-limited-treatment-options/> ;
  schema:addressCountry "ES" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/all-leukemia/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:trials <https://onco.cc/trials/nct07471789/> .